Intervention

tipranavir

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

5 shown

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive PatientsNCT00530920 · 2007-10-01

Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & EfficacyNCT00615290 · 2007-06-01

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot EvaluationNCT00447902 · 2007-03-01

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoCNCT00440271 · 2007-02-01

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsNCT00056641 · 2003-02-18

Common conditions

HIV Infections5

Leading sponsors

Boehringer Ingelheim5

Trial status mix

COMPLETED3

TERMINATED2

Phase mix

PHASE22

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.